500 related articles for article (PubMed ID: 2572437)
1. Effects of sulfasalazine and a sulfasalazine analogue on the formation of lipoxygenase and cyclooxygenase products.
Tornhamre S; Edenius C; Smedegård G; Sjöquist B; Lindgren JA
Eur J Pharmacol; 1989 Oct; 169(2-3):225-34. PubMed ID: 2572437
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of platelet thromboxane synthetase by sulfasalazine.
Stenson WF; Lobos E
Biochem Pharmacol; 1983 Jul; 32(14):2205-9. PubMed ID: 6135423
[TBL] [Abstract][Full Text] [Related]
3. Modulation of human colonic arachidonic acid metabolism by sulfasalazine.
Hawkey CJ; Boughton-Smith NK; Whittle BJ
Dig Dis Sci; 1985 Dec; 30(12):1161-5. PubMed ID: 2866075
[TBL] [Abstract][Full Text] [Related]
4. A comparison of effects of sulfasalazine and its metabolites on the metabolism of endogenous vs. exogenous arachidonic acid.
Allgayer H; Stenson WF
Immunopharmacology; 1988; 15(1):39-46. PubMed ID: 2896181
[TBL] [Abstract][Full Text] [Related]
5. Effect of indomethacin on arachidonic acid metabolism in human leukocytes stimulated ex vivo.
Docherty JC; Wilson TW
Clin Pharmacol Ther; 1991 Mar; 49(3):294-9. PubMed ID: 1848800
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of leukotriene formation in human leukocytes by halothane.
Yamaoka A; Sumimoto H; Takeshige K; Itoh T; Isobe R; Yoshitake J; Minakami S
Biochim Biophys Acta; 1987 Apr; 918(3):284-92. PubMed ID: 3032266
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of leukotriene (LT) and hydroxy eicosatetraenoic acid (HETE) synthesis in human leukocytes in vitro: effect of arachidonic acid concentration.
Fruteau de Laclos B; Braquet P; Borgeat P
Prostaglandins Leukot Med; 1984 Jan; 13(1):47-52. PubMed ID: 6324240
[TBL] [Abstract][Full Text] [Related]
8. Lipoxygenase pathways of macrophages.
Bonney RJ; Opas EE; Humes JL
Fed Proc; 1985 Nov; 44(14):2933-6. PubMed ID: 2996948
[TBL] [Abstract][Full Text] [Related]
9. Sulfasalazine and 5-aminosalicylic acid inhibit contractile leukotriene formation.
Nielsen ST; Beninati L; Buonato CB
Scand J Gastroenterol; 1988 Apr; 23(3):272-6. PubMed ID: 2898806
[TBL] [Abstract][Full Text] [Related]
10. In vitro effects of E3040, a dual inhibitor of 5-lipoxygenase and thromboxane A(2) synthetase, on eicosanoid production.
Oketani K; Nagakura N; Harada K; Inoue T
Eur J Pharmacol; 2001 Jun; 422(1-3):209-16. PubMed ID: 11430933
[TBL] [Abstract][Full Text] [Related]
11. Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils.
Lee TH; Mencia-Huerta JM; Shih C; Corey EJ; Lewis RA; Austen KF
J Clin Invest; 1984 Dec; 74(6):1922-33. PubMed ID: 6096400
[TBL] [Abstract][Full Text] [Related]
12. Characterization of CGS 8515 as a selective 5-lipoxygenase inhibitor using in vitro and in vivo models.
Ku EC; Raychaudhuri A; Ghai G; Kimble EF; Lee WH; Colombo C; Dotson R; Oglesby TD; Wasley JW
Biochim Biophys Acta; 1988 Apr; 959(3):332-42. PubMed ID: 2833314
[TBL] [Abstract][Full Text] [Related]
13. High-performance liquid chromatographic quantitation of cyclooxygenase and lipoxygenase metabolites of arachidonic acid from rat polymorphonuclear leukocytes.
Tordjman C; Serkiz B; Rambaud F; Bonnet J; Volland JP
J Chromatogr; 1990 Oct; 532(1):135-43. PubMed ID: 1964162
[No Abstract] [Full Text] [Related]
14. Intracellular retention of the 5-lipoxygenase pathway product, leukotriene B4, by human neutrophils activated with unopsonized zymosan.
Williams JD; Lee TH; Lewis RA; Austen F
J Immunol; 1985 Apr; 134(4):2624-30. PubMed ID: 2982947
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of 5-lipoxygenase pathway of arachidonic acid metabolism in human neutrophils by sulfasalazine and 5-aminosalicylic acid.
Nielsen OH; Bukhave K; Elmgreen J; Ahnfelt-Rønne I
Dig Dis Sci; 1987 Jun; 32(6):577-82. PubMed ID: 2882965
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of ionophore-stimulated leukotriene B4 production in human leucocytes by monohydroxy fatty acids.
Camp RD; Fincham NJ
Br J Pharmacol; 1985 Aug; 85(4):837-41. PubMed ID: 2994785
[TBL] [Abstract][Full Text] [Related]
17. Modulation of alveolar macrophage-derived 5-lipoxygenase products by the sulfhydryl reactant, N-ethylmaleimide.
Peters-Golden M; Shelly C
J Biol Chem; 1987 Aug; 262(22):10594-600. PubMed ID: 3112148
[TBL] [Abstract][Full Text] [Related]
18. 1-[4-[3-[4-[bis(4-fluorophenyl)hydroxymethyl]-1- piperidinyl]propoxy]-3-methoxyphenyl]ethanone(AHR-5333): a selective human blood neutrophil 5-lipoxygenase inhibitor.
Graff G; Anderson LA
Prostaglandins; 1989 Oct; 38(4):473-96. PubMed ID: 2554366
[TBL] [Abstract][Full Text] [Related]
19. Ebselen reduces the formation of LTB4 in human and porcine leukocytes by isomerisation to its 5S, 12R-6-trans-isomer.
Kuhl P; Borbe HO; Fischer H; Römer A; Safayhi H
Prostaglandins; 1986 Jun; 31(6):1029-48. PubMed ID: 3020614
[TBL] [Abstract][Full Text] [Related]
20. Detection of a novel cyclooxygenase metabolite produced by human promyelocytic leukemia (HL-60) cells.
Agins AP; Hollmann AB; Agarwal KC; Wiemann MC
Biochem Biophys Res Commun; 1985 Jan; 126(1):143-9. PubMed ID: 2982366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
